Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pfizer

Pfizer halts trials in Russia but will continue to supply drugs

Pfizer Inc. said it would no longer start new clinical trials in Russia and that it would donate all profits from its subsidiary in the country to Ukraine relief causes.

Tribune News Service

Pfizer CEO says fourth vaccine dose will be needed

CDC only authorised third jab for most adults in the fall

The Independent UK

Pfizer To Stop New Clinical Trials In Russia: Reuters

Reuters reported that Pfizer Inc (NYSE: PFE) said it wo

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Here's Why Pfizer And Novavax Shares Are Rising On Monday

Pfizer Inc. (NYSE: PFE) and Novavax, Inc. (NASDAQ: NVAX) shares are trading higher by 4.3% at $52.42 and 9.6% at $80.05 respectively. Strength is possibly due to a spike in COVID-19 cases in China, which could lift vaccine sector sentiment.

Benzinga

Pfizer-BioNTech's COVID-19 Shot Moderately Effective Against Omicron In Kids Aged 5 to 15, CDC Study Shows

The Pfizer Inc (NYSE: PFE) - BioNTech SE (NASDAQ: BNTX) vaccine is only moderately effective against the omicron variant when tested in children ages 5 to 15.

Benzinga

Fourth COVID shot will be ‘necessary,’ says Pfizer CEO

COVID-19 shots could soon become an annual item on your to-do list.

Tribune News Service

Pfizer’s Covid-19 Drug Arrives in Hong Kong, City’s Leader Says

The first batch of 75 Chinese mainland medical personnel has also arrived in Hong Kong to boost the city’s capacity to treat severe cases amid the worst local outbreak

Caixin Global

Read news from The Economist, FT, and more,
with one subscription

Pfizer, Bayer to maintain drug supply to Russia

Pfizer Inc and Bayer said on Monday they would maintain humanitarian supply of medicines to Russia, but would pull back from other non-essential spending in the country.

Reuters

Pfizer vaccine reduces Covid infections in children, research finds

It also reduces the severity for those that do catch the virus

Wales Online

Covid-19 vaccine ‘reduces infections in children’ – study

It is expected that five to 11-year-olds in England will be called forward for vaccines in April.

The Independent UK

Two years into the pandemic, unequal access to COVID-19 treatments threatens the global recovery

It’s now two years since the World Health Organization began calling the COVID-19 outbreak a pandemic.

The Conversation

Weekly Must-Read: China Meheco Confirms Pfizer Talks on Selling Paxlovid in China

State-owned drugmaker’s shares surge by 10% limit on four straight days in Shanghai, though its role may be limited to distribution logistics

Caixin Global

Which companies aren’t exiting Russia? Big pharma

Even as the war in Ukraine has prompted an exodus of international companies — from fast-food chains and oil producers to luxury retailers — from Russia, U.S. and global drug companies said they would continue manufacturing and selling their products there.

Tribune News Service

George Christensen says 'elites' have suddenly started hiding vaccinated death statistics. Here's why that's wrong

Coalition backbencher George Christensen took to Facebook this week to claim the government has suddenly stopped reporting vaccinated death statistics. Is that correct?

ABC News

Get all your
news in one place.

100's of premium titles.
One news app.

Al Jazeera

Africa CDC signs MOU with Pfizer to supply COVID-19 pills

The confirmation from Africa’s top public health agency comes within days of Modena and J&J announcing deals in Africa.

The Independent UK

Ukraine publishes list of 50 global brands that are continuing to operate in Russia

Burger King suspends operations in Russia after being named on list alongside Pfizer, Johnson and Johnson and Samsung Electronics

Tribune News Service

Vacunados con J&J, reforzados con ARNm, y pensando en la tercera dosis

Sí, todos estamos agotados por la pandemia de covid. Desconcertados por los constantes cambios en la ciencia y en las directrices. Preocupados por la sucesión de nuevas y temibles variantes, cada una con su propio nombre, como los huracanes.

Tribune News Service

Pfizer studying COVID pill Paxlovid in children age 6 and older

Pfizer Inc. said it launched a study of its oral Covid-19 treatment among children age 6 and up who have been infected by the virus and are at risk of progressing to severe disease.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Pfizer's Paxlovid Becomes First Oral COVID-19 Therapy To Be Evaluated In Pediatric Clinical Study

Pfizer Inc (NYSE: PFE) has initiated a Phase 2/3 EPIC-PEDS trial to evaluate Paxlovid (nirmatrelvir and ritonavir tablets)

Benzinga

The Daily Biotech Pulse: Pfizer Begins Late-Stage Pediatric COVID Pill Study, Midatech And J&J Unit Expand R&D Collaboration, AbbVie-Alvotech Settle Humira Dispute

Here's a roundup of top developments in the biotech space over the last 24 hours.

The Independent UK

Pfizer CEO claims Jared Kushner wanted to reroute vaccines from Canada and Latin America to US

‘Jared didn’t budge. In his mind, America was coming first no matter what,’ Albert Bourla writes

Salon

No, vaccines in kids aren't failing

More research is needed, but likely omicron is to blame and not an overly low dosage for children

Benzinga

Looking At Pfizer's Recent Whale Trades

A whale with a lot of money to spend has taken a noticeably bullish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 27 strange trades.

Reuters

South Africa risks destroying 100,000 vaccine doses by end-March due to slow uptake

About 100,000 doses of Pfizer's COVID-19 vaccine are at risk of being destroyed by the end of this month due to slow uptake by citizens, South African health authorities said on Friday.

Benzinga

Pfizer Commits 10M Courses Of COVID-19 Oral Antiviral To Developing Countries: Reuters

Pfizer Inc (NYSE:PFE) is expected to provide around 10 million courses of its highly effective COVID-19 antiviral treatment Paxlovid to low- and middle-income countries in 2022, reports Reuters citing an official with the Global Fund. The Fund's head of strategy for policy, Harley Feldbaum, said Pfizer had committed at least that many…

1 … 62 63 64 65

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.